About 1,300,959 results (2,876 milliseconds)

Development of antibody-dependent cellular cytotoxicity in response ...

https://news.google.com/__i/rss/rd/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvczQxNTQxLTAyMi0wMDU0NS0y0gEA?oc=5
Oct 25, 2022 ... These results indicated that the combination of VZV antibodies and ... IgG Antibody Response in Varicella-Zoster Virus Infections. J ...

US20120034267A1 - Inactivated varicella zoster virus vaccines ...

https://patents.google.com/patent/US20120034267A1/en
Results show that antibody (IgG) responses were reduced in mice following ... VZV antigen content but were inactivated at different gamma-irradiation levels.

WO2012018973A1 - Inactivated varicella zoster virus vaccines ...

https://patents.google.com/patent/WO2012018973A1/en
Results show that antibody (IgG) responses were reduced in mice following ... VZV antigen content but were inactivated at different gamma-irradiation levels.

EP3906940A1 - Recombinant varicella-zoster virus vaccine ...

https://patents.google.com/patent/EP3906940A1/en
In the ELISA test, 127 serum samples from children at 0 to 10 years old are tested for VZV-IgG antibodies, with a total positive rate of 81.89%, and a ...

EP2281831B1 - Varicella Zoster virus vaccine - Google Patents

https://patents.google.com/patent/EP2281831B1/en
Antibody levels against VZV and gE will be measured using ... Seropositivity rates and GMTs for VZV IGG antibodies (ATP cohort for immunogenicity) ...

CA3125908A1 - Recombinant varicella-zoster virus (vzv) vaccine ...

https://patents.google.com/patent/CA3125908A1/en
In the ELISA test, 127 serum samples from children at 0 to 10 years old are tested for VZV-IgG antibodies, with a total positive rate of 81.89%, and a ...

US20050202413A1 - Varicella zoster virus (VZV) immunoreactive ...

https://patents.google.com/patent/US20050202413A1/en
Cross reactivity with HSV-specific antibodies, and, consequent, false-positive results, thus are frequently observed in glycoprotein ELISAs, due to pronounced ...

CN102517302A - Method for recombinant expression of varicella ...

https://patents.google.com/patent/CN102517302A/en
negative (the IFAT method mensuration) plasma sample of VZV IgG (FAMA method mensuration) strong positive (>=1: 32), be mostly zoster reconvalescent plasma ...

US5789232A - Process for isolating a viral antigen preparation ...

https://patents.google.com/patent/US5789232
After antigen adsorption, an anti-VZV IgG-positive and an anti-VZV IgG ... Preparation of the "UC pellet" antigen from varicella zoster (VZV)-infected cells.

US4634666A - Human-murine hybridoma fusion partner - Google ...

https://patents.google.com/patent/US4634666A/en
some of these were again subcloned, and at least two of the subclones assayed from both patent wells showed anti-VZV IgG levels >10 μg/10 6 cells/24 hours as ...

US7939084B1 - Vaccine against varicella zoster virus - Google ...

https://patents.google.com/patent/US7939084B1/en
Antibody levels against VZV and gE will be measured using classical ELISA assays. ... Seropositivity rates and GMTs for VZV IGG antibodies (ATP. cohort for ...

EP2281830A2 - Varicella Zoster virus vaccine - Google Patents

https://patents.google.com/patent/EP2281830A2/en
Antibody levels against VZV and gE will be measured using classical ELISA assays. ... Seropositivity rates and GMTs for VZV IGG antibodies (ATP cohort for ...

WO2017070601A1 - Nucleic acid vaccines for varicella zoster virus ...

https://patents.google.com/patent/WO2017070601A1/nl
VZV antigen vaccines including significantly higher levels of IgG production by mRNA chemically modified and unmodified VZV vaccines formulated in LNP ...

US5506132A - Human antibodies against varicella-zoster virus ...

https://patents.google.com/patent/US5506132A/en
The invention provides human monoclonal antibodies specific for the glycoprotein II subunit of Varicella-zoster virus. Preferred antibodies exhibit strong ...

WO1994002596A1 - Method for preventing zoster or alleviating ...

https://patents.google.com/patent/WO1994002596A1/en
... herpes zoster with varicella zoster virus (VZV) antigen ... VZV antibodies or positive response to a VZV antigen skin test. Particularly ...

WO2018170270A1 - Varicella zoster virus (vzv) vaccine - Google ...

https://patents.google.com/patent/WO2018170270A1/en
... IgG levels, sufficient for prophylactic and therapeutic methods rather than transient IgM responses. ... The primary varicella zoster virus infection that results ...

US20070072240A1 - Method for producing an in vitro expression ...

https://patents.google.com/patent/US20070072240A1/en
Generation and Screening of a Varicella Zoster Virus Patient Antibody Library. Discussion: [0189] ... The positive control is from a person who had a Varicella ...

WO2018124615A1 - Herpes zoster vaccine composition - Google ...

https://patents.google.com/patent/WO2018124615A1/en
IgG titers and VZV-specific T cell immune responses were identified, and the experimental results are summarized in FIG. 12.

US20230374079A1 - Nucleic acid vaccines for varicella zoster virus ...

https://patents.google.com/patent/US20230374079A1/en?oq=US20230374079A1
In contrast to the findings observed with siRNA, the LNP-mRNA formulations of the invention are demonstrated herein to generate enhanced IgG levels, sufficient ...